-+ 0.00%
-+ 0.00%
-+ 0.00%

Autolus Therapeutics Q3 EPS $(0.30) Misses $(0.22) Estimate, Sales $21.194M Miss $21.311M Estimate

Benzinga·11/12/2025 12:02:20
Listen to the news
Autolus Therapeutics (NASDAQ:AUTL) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.22) by 36.99 percent. This is a 3.23 percent increase over losses of $(0.31) per share from the same period last year. The company reported quarterly sales of $21.194 million which missed the analyst consensus estimate of $21.311 million by 0.55 percent.